secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2024-05-24T23:59:59+00:00
Accession:  0001493152-24-021342
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros stockholders approve 2024 Equity Incentive Plan authorizing 2,616,875 shares
--------------------------------------------------------------------------------

- Plan adds 900,000 new shares plus prior plan reserve and returning shares; total shares authorized 2,616,875.
- Stockholders elected directors Arthur H. Amron (6,860,037 for) and Oliver Spandow (6,690,864 for).
- Ratified Baker Tilly US, LLP as independent auditor for FY2024 (8,545,420 for, 21,330 against).
- Advisory say-on-pay approved with 6,832,340 for, 62,907 against.
- Prior plan no longer available for new grants; all outstanding awards remain subject to prior terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315224021342/0001493152-24-021342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315224021342/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-021342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer